semaglutide and tirzepatide equivalent doses Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are Switching from semaglutide to tirzepatide

These compounds act through modulation of neuroinflammation and oxidative stress by regulating microglial activation and reducing proinflammatory cytokines (Veselinovi et al., 2021)

In total, 42 animal and human studies were included in the final review (Fig

People lost an average of 20.2% of their body weight with tirzepatide compared to 13.7% with semaglutide

A meta-analysis evaluated eight randomized controlled trials that assessed cardiovascular outcomes in patients with diabetes who had supplemented with omega-3 fatty acids

Potential Side Effects and Considerations IV

These include: Lightheadedness Fatigue or weakness Mild shakiness Headaches Nausea Without checking blood glucose, its easy to assume hypoglycemia when the real issue is delayed digestion, dehydration, or inadequate nutrition